Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Mon, 27th Jul 2015 05:16

UK Earnings, Trading Statements Calendar 
Monday, July 27 
DialightHalf Year Results
Reckitt BenckiserHalf Year Results
HiscoxHalf Year Results
Acacia MiningHalf Year Results
CranswickQ1 Interim Management Statement
Scottish American Investment CompanyHalf Year Results
XP PowerHalf Year Results
SeniorHalf Year Results
Fevertree DrinksHalf Year Results
Nakama GroupFull Year Results
Tuesday, July 28 
BPHalf Year Results
GKNHalf Year Results
NextQ2 Trading Statement
GreencoreInterim Management Statement
Provident Financial GroupHalf Year Results
McColl's RetailHalf Year Results
ShawbrookHalf Year Results
Virgin MoneyHalf Year Results
SEGROHalf Year Results
Tullett PrebonHalf Year Results
Rathbone BrothersHalf Year Results
InformaHalf Year Results
Domino's Pizza GroupHalf Year Results
ITVHalf Year Results
Jardine Lloyd ThompsonHalf Year Results
International Game TechnologyHalf Year Results
PaceHalf Year Results
Greencoat UK WindHalf Year Results
Burford CapitalHalf Year Results
Games Workshop Half Year Results
DraxHalf Year Results
ElementisHalf Year Results
CarpetrightHalf Year Results
Wednesday, July 29 
Brewin DolphinInterim Management Statement
Capital Counties & PropertiesHalf Year Results
AntofagastaQ2 Production Report
Compass GroupInterim Management Statement
DignityHalf Year Results
DiplomaQ3 Results
BarclaysHalf Year Results
British American TobaccoHalf Year Results
GlaxoSmithKlineQ2 Results
4imprintHalf Year Results
Jupiter Fund ManagementHalf Year Results
Lancashire HoldingsQ2 Resiults
RightmoveHalf Year Results
International Personal FinanceHalf Year Results
FoxtonsHalf Year Results
Pets At HomeTrading Update
Polymetal InternationalQ2 Production Report
TSB Banking GroupHalf Year Results
RenishawHalf Year Results
Tate & LyleInterim Management Statement
Tarsus GroupHalf Year Results
CapitaHalf Year Results
Taylor WimpeyHalf Year Results
Riverstone EnergyHalf Year Results
Stanley GibbonsTrading Update
Paragon GroupQ3 Interim Management Statement 
Aberforth Smaller Cos TrustHalf Year Results
SkyFull Year Results
JKX Oil & Gas Half Year Results
Circassia PharmaceuticalsHalf Year Results
St James's PlaceHalf Year Results
TymanHalf Year Results
WS AtkinsHalf Year Results
Law DebentureHalf Year Results
Mithras Investment TrustHalf Year Results
National ExpressHalf Year Results
Tullow OilHalf Year Results
Man GroupHalf Year Results
Telecity Half Year Results
Essar EnergyQ1 Results
FDM GroupHalf Year Results
IndiviorHalf Year Results
Mitchells & ButlersQ3 Interim Management Statement 
Thursday, July 30 
AstraZenecaHalf Year Results
Royal Dutch ShellHalf Year Results
CentricaHalf Year Results
Intercontinental Hotels GroupHalf Year Results
Halfords GroupQ1 Interim Management Statement 
InchcapeHalf Year Results
Moneysupermarket.comHalf Year Results
Hemderson GroupHalf Year Results
LairdHalf Year Results
Millennium & Copthorne HotelsHalf Year Results
SpectrisHalf Year Results
SchrodersHalf Year Results
BAE SystemsHalf Year Results
Rolls Royce HoldingsHalf Year Results
Royal Bank of Scotland GroupHalf Year Results
Babcock InternationalTrading Update
Smith & NephewHalf Year Results
CountrywideHalf Year Results
3i GroupInterim Management Statement
VictoriaFull Year Results
BodycoteHalf Year Results
BT GroupHalf Year Results
Centaur MediaHalf Year Results
CommunisisHalf Year Results
DiageoHalf Year Results
Intu PropertiesHalf Year Results
KAZ MineralsQ2 Production Report
Management Consulting Group Half Year Results
Merlin EntertainmentsHalf Year Results
RPS GroupHalf Year Results
Thomas CookQ3 Interim Management Statement 
Weir GroupHalf Year Results
XchangingHalf Year Results
Rentokil InitialHalf Year Results
RexamHalf Year Results
Robert WaltersHalf Year Results
Friday, July 31 
UBMHalf Year Results
BerendsenHalf Year Results
NWF GroupHalf Year Results
Colt GroupHalf Year Results
BG GroupHalf Year Results
International Consolidated Airlines GroupHalf Year Results
Lloyds Banking GroupHalf Year Results
IMIHalf Year Results
VedantaQ1 Production Results
EssentraHalf Year Results
VesuviusHalf Year Results
AlentHalf Year Results
SophosTrading Statement 
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.